Market Closed -
Other stock markets
|
Pre-market 12:20:48 | |||
40.25 USD | 0.00% | 40.58 | +0.83% |
05-30 | Bristol-Myers Squibb Says Breyanzi Gets FDA Approval as CAR T Cell Therapy for Mantle Cell Lymphoma | MT |
05-30 | Bristol Myers: FDA approval for Breyanzi | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.56% | 81.59B | |
+39.82% | 734B | |
+32.65% | 591B | |
-7.31% | 350B | |
+14.23% | 315B | |
+0.86% | 276B | |
+14.13% | 238B | |
-6.34% | 204B | |
+8.74% | 206B | |
+4.51% | 161B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Goldman Sachs Adjusts Price Target on Bristol-Myers Squibb to $69 From $81, Maintains Buy Rating